Diabetes Drug Dapagliflozin May Cause Bladder And Breast Cancers, Says FDA
A new diabetes pill dapagliflozin is effective but may cause bladder and breast cancer, says the FDA as it decides whether to approve the medication.
My interpretation, as I have presented in most of my books, is:
Excess free calcium within the body gets removed from the body through approximately 8 urinations, to the extent of making the Input/Ouput Ratio to remain at 1.0, for most of the time. That leaves the body in good health.
Over a period of time, repeated retentions of such excessive calcium results in an excessive accumulation, reaching a level that is beyond the tolerance limit (threshold point) of the body.
(There are scientific papers that indicate the rapid absorption of glucose by the cells that make up the cancer. This may enlarge the cancer structure. However, this is not the point I am interested in indicating here.)
My suspicion, with reference to the possible development of cancers doubted to be related to the new diabetic drug right now is:
IF THE NEW DRUG DECREASED THE FREE FLOW OF URINE, AND ENHANCE ITS RETENTION WITHIN THE BODY, THERE IS EVERY ROOM FOR THE DEVELOPMENT OF CANCERS.
THE ABOVE IS MORE PROBABLE BECAUSE, THE URINE THAT GETS STAGNATED IN THE URINAL BLADDER CAN MAKE AVAILABLE ITS CALCIUM CONTENT TO BE ABSORBED BY THE CELLS THAT MAKE UP THE INTERNAL WALL OF THE BLADDER (BY THE EPITHELIAL CELLS, THUS GIVING RISE TO CARCINOMAS, AND NOT SARCOMAS), AND GIVE RISE TO BLADDER CANCER.
MY INTERPRETATION APPEARS TO GET STRENGTHENED BY THE FOLLOWING STATEMENT MADE BY THE FDA: “…does not work so well in diabetes patients with impaired kidney function…”.
WHEN IT COMES TO THE BREAST, THE LACTICIFEROUS (milk ducts) TISSUES THERE THAT ARE DESIGNED TO SCAVENGE CALCIUM FROM ALL SOURCES (IN ORDER TO PRODUCE / SECRETE MILK) TEND TO ABSORB THE FREE CALCIUM THAT GETS RETAINED WITHIN THE BODY DUE TO UNDER-URINATION PROBABLY CAUSED BY THE NEW DIABETIC DRUG.